# Niagen Bioscience, Inc.: Form 8-K, filed May 7, 2025

- Company: [Niagen Bioscience, Inc.](/companies/nage.md) (CIK 1386570)
- Form: 8-K
- Filed: 2025-05-07
- Accepted by EDGAR: May 7, 2025, 16:01 ET
- Period: 2025-05-07
- Accession: 0001628280-25-023129
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1386570/000162828025023129/cdxc-20250507.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1386570/000162828025023129/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1386570/000162828025023129/cdxc-20250507.htm

Filed May 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-023129. Last ingested by Listed: Nov 4, 2026, 16:21 ET. No prices; not investment advice.